Magic Hour
SoCal Gas
You are here:  Home  >  Biotech  >  Current Article

Amgen earnings beat expectations

By   /   Tuesday, October 29th, 2019  /   Comments Off on Amgen earnings beat expectations

    Print       Email
Revenue at Amgen continued to decline in the third quarter, but net income climbed nearly 6 percent while stock buybacks propelled earnings per share up 14 percent. Revenue fell 3 percent to $5.7 billion, as biosimilar and generic competitors continued to eat into the Thousand Oaks biotech giant’s core products, such as white blood cell…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Bank of the Sierra gives $1M to Housing Trust Fund Ventura County

Read More →